Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives -
Top Cited Papers
Open Access
- 1 January 2010
- journal article
- review article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 74 (5), 818-826
- https://doi.org/10.1253/circj.cj-10-0110
Abstract
Statins are 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, which are widely used to lower serum cholesterol levels in the primary and secondary prevention of cardiovascular disease. Recent experimental and clinical evidence suggests that the beneficial effects of statins may extend beyond their cholesterol-lowering effects, to include so-called pleiotropic effects. These cholesterol-independent effects include improving endothelial function, attenuating vascular and myocardial remodeling, inhibiting vascular inflammation and oxidation, and stabilizing atherosclerotic plaques. The mechanism underlying some of these pleiotropic effects is the inhibition of isoprenoid synthesis by statins, which leads to the inhibition of intracellular signaling molecules Rho, Rac and Cdc42. In particular, inhibition of Rho and one of its downstream targets, Rho kinase, may be a predominant mechanism contributing to the pleiotropic effects of statins. The aim of the present review is to provide an update on the non-cholesterol-dependent statin effects in the cardiovascular system and highlight some of the recent findings from bench to bedside to support the concept of statin pleiotropy. (Circ J 2010; 74: 818 - 826)Keywords
This publication has 119 references indexed in Scilit:
- A Randomized Trial of Rosuvastatin in the Prevention of Venous ThromboembolismNew England Journal of Medicine, 2009
- Simvastatin enhances bone marrow stromal cell differentiation into endothelial cells via notch signaling pathwayAmerican Journal of Physiology-Cell Physiology, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- A Method for Measuring Rho Kinase Activity in Tissues and CellsMethods in enzymology, 2008
- Pleiotropic effects of statin therapy: molecular mechanisms and clinical resultsTrends in Molecular Medicine, 2008
- Increased Rho Kinase Activity in a Taiwanese Population With Metabolic SyndromeJournal of the American College of Cardiology, 2007
- Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic MechanismsNature Reviews Drug Discovery, 2005
- Inflammation in atherosclerosisNature, 2002
- Regulation of the mevalonate pathwayNature, 1990